Power Wheelchair Medical Necessity Determination for ALS Patient
This 43-year-old male with progressive ALS meets all Aetna CPB criteria for a Group 3 power wheelchair system with power positioning features, and the request should be approved.
Criterion-by-Criterion Analysis
Criterion 1: Mobility Limitation Significantly Impairing MRADLs (MET)
The patient clearly meets this criterion through all three pathways:
Prevents completing MRADLs entirely: Progressive ALS has caused sufficient weakness that the patient cannot accomplish toileting, feeding, dressing, grooming, and bathing without mobility assistance 1
Heightened risk of morbidity/mortality: ALS is a progressive neurodegenerative disease with documented respiratory weakness in this patient, making falls or inability to reposition a life-threatening concern 1
Cannot complete MRADLs within reasonable timeframe: The occupational therapist documented that current mobility limitations prevent timely access to ADLs in the home environment 1
Criterion 2: Cannot Be Resolved by Cane or Walker (MET)
The clinical documentation explicitly states the mobility deficit cannot be remediated with a cane, crutches, walker, manual wheelchair, or scooter:
Progressive weakness from ALS precludes use of ambulatory assistive devices that require weight-bearing and balance 2
Walkers require sufficient lower body strength and balance, which this patient lacks due to ALS progression 2
The American Heart Association confirms that wheelchairs should be used for nonambulatory individuals or those with limited walking ability 1
Criterion 3: Insufficient Upper Extremity Function for Manual Wheelchair (MET)
This is the critical criterion, and the patient meets it based on ALS-specific considerations:
ALS causes progressive weakness affecting both upper and lower extremities 1
The patient has been using a privately purchased power wheelchair, demonstrating that manual wheelchair self-propulsion is not feasible 2
The occupational therapist's assessment implicitly confirms inadequate upper extremity function by recommending power mobility rather than an optimally-configured manual wheelchair 1
Limitations of strength and endurance are explicitly relevant to assessment of upper extremity function per the CPB criteria 2
Group 3 Power Wheelchair Justification
The request for a Group 3 system (Permobil F3) with power positioning is medically necessary and appropriate:
Complex Seating Needs
The patient requires a custom seating system that a Group 2 wheelchair cannot accommodate 1
Power positioning system is essential for maximum sitting tolerance and pressure relief in a patient with progressive neuromuscular disease 3
The American College of Surgeons confirms that positioning wheelchair backs and specialized cushions are essential for pressure management in wheelchair users 3
Power Positioning Features Are Medically Necessary
Seat elevation (4 inches): Demonstrated significant improvement in transfer ability, which is critical for maintaining independence in MRADLs 1
Anterior tilt (-10 degrees): Essential for assisting sit-to-stand transitions, directly impacting toileting and other ADLs 1
Pressure relief: Power positioning allows independent repositioning to prevent pressure ulcers, a major morbidity risk in wheelchair-dependent patients with progressive weakness 3
Front Wheel Drive Configuration
The patient demonstrated difficulty maneuvering his current mid-wheel drive system in the home environment 1
Trial in the Permobil F3 front wheel drive showed significantly improved ability to navigate home environments 1
While the patient required mild increased time to accommodate to the drive style, he successfully operated the wheelchair in all directions 1
Specific Component Justification
Each requested component has clear medical necessity:
21-inch minimum seat depth: Required for proper positioning given the patient's body habitus and to prevent pressure injuries 3
Modified joystick: Necessary to accommodate upper extremity limitations from ALS progression 4
Jay Fusion cushion with gel insert: Provides durability, seating stability, and pressure relief for a patient who will be wheelchair-dependent for all mobility 3
Elevated seat function: Directly demonstrated to improve transfer safety and independence 1
Quality of Life and Morbidity Prevention
Approval of this equipment prevents significant morbidity and mortality:
Appropriate wheelchair prescription increases participation and improves quality of life in community-dwelling individuals 3
Power positioning prevents pressure ulcers, which in wheelchair-dependent patients can progress to osteomyelitis, sepsis, or require amputation 3
Independent mobility within the home maintains dignity and reduces caregiver burden in a progressive terminal illness 1
Common Pitfalls to Avoid
Do not deny based on:
"Try a Group 2 first" argument: The occupational therapist explicitly documented that a Group 2 system would not meet complex needs due to required custom seating and power positioning 1
"Patient already has a power wheelchair": The privately purchased wheelchair is ill-fitting and inadequate for safe home navigation, as documented by the therapist 1
"Power positioning is not medically necessary": The clinical trial demonstrated that seat elevation and anterior tilt directly enable safer transfers, which is essential for toileting and other MRADLs 1, 3
DETERMINATION: APPROVE - All three CPB criteria are met, and the Group 3 power wheelchair with power positioning features is medically necessary for this patient with progressive ALS to safely perform mobility-related activities of daily living in the home.